器官移植市場－全球產業規模、佔有率、趨勢、機會和預測，按產品、應用、移植類型、最終用戶、地區和競爭細分，2020-2030 年

2024 年全球器官移植市場價值為 145.6 億美元，預計在預測期內將呈現令人印象深刻的成長，到 2030 年的複合年成長率為 8.93%。器官移植市場主要涉及器官移植程序。器官移植是一種醫療干預，從一個身體提取器官並植入另一個身體以解決器官衰竭、填補空白或替換受損或缺失的器官。此程序通常用於治療肺、腎、肝等重要器官的器官衰竭。最常見的器官移植候選人是腦死但擁有健康器官的人，這些器官有可能挽救他人的生命。在進行此複雜的程序之前，獲得患者或其家人的同意至關重要，因為未經同意摘取器官被視為非法和應受譴責的行為。例如，截至2024年2月，美國衛生資源與服務管理局（HRSA）報告稱，美國全國器官移植候補名單上約有103,223人，包括男性、女性和兒童。預計主要國家對移植手術的旺盛需求將在預測期內顯著推動市場成長。

關鍵市場促進因素

器官衰竭和器官捐贈程序

主要市場挑戰

移植排斥

主要市場趨勢

技術和發展的進步

目錄

第 1 章：產品概述

第2章：研究方法

第3章：執行摘要

第4章：顧客之聲

第5章：全球器官移植市場展望

• 市場規模和預測
  • 按價值
• 市場佔有率和預測
  • 依產品（組織產品、器官保存產品、移植診斷產品、免疫抑制藥物等）
  • 依應用（器官移植、組織移植）
  • 依移植類型（自體移植、同種異體移植、其他）
  • 按最終使用者（醫院、移植中心等）
  • 按地區
  • 按公司分類（2024）
• 市場地圖

第6章：北美器官移植市場展望

• 市場規模和預測
• 市場佔有率和預測
• 北美：國家分析
  • 美國
  • 加拿大
  • 墨西哥

第7章：歐洲器官移植市場展望

• 市場規模和預測
• 市場佔有率和預測
• 歐洲：國家分析
  • 德國
  • 英國
  • 義大利
  • 法國
  • 西班牙

第8章：亞太器官移植市場展望

• 市場規模和預測
• 市場佔有率和預測
• 亞太地區：國家分析
  • 中國
  • 印度
  • 日本
  • 韓國
  • 澳洲

第9章：南美洲器官移植市場展望

• 市場規模和預測
• 市場佔有率和預測
• 南美洲：國家分析
  • 巴西
  • 阿根廷
  • 哥倫比亞

第10章：中東與非洲器官移植市場展望

• 市場規模和預測
• 市場佔有率和預測
• MEA：國家分析
  • 南非
  • 沙烏地阿拉伯
  • 阿拉伯聯合大公國

第 11 章：市場動態

• 驅動程式
• 挑戰

第 12 章：市場趨勢與發展

• 合併與收購（如有）
• 產品發布（如有）
• 最新動態

第 13 章：波特五力分析

• 產業競爭
• 新進入者的潛力
• 供應商的力量
• 顧客的力量
• 替代產品的威脅

第 14 章：競爭格局

• Abbvie, Inc.
• Arthrex, Inc.
• Zimmer Biomet
• Medtronic plc
• Novartis AG
• Stryker Corporation
• 21st Century Medicine
• BiolifeSolutions, Inc.
• Teva Pharmaceuticals Industries Ltd.
• Veloxis Pharmaceutical Inc.

第 15 章：策略建議

第16章調查會社について,免責事項

Global Organ Transplant Market was valued at USD 14.56 Billion in 2024 and is anticipated to project impressive growth in the forecast period with a CAGR of 8.93% through 2030F. The organ transplantation market primarily deals with the procedure of transplanting organs. Organ transplantation is a medical intervention wherein an organ is extracted from one body and implanted into another to address organ failure, fill a void, or replace a damaged or missing organ. This procedure is commonly employed to treat organ failure in vital organs such as the lungs, kidneys, liver, and others. Candidates most commonly considered for organ transplantation are individuals with brain death yet possessing healthy organs that can potentially save another person's life. Prior to undertaking this intricate procedure, obtaining the consent of the patient or their family is of utmost importance, as organ harvesting without consent is deemed an illegal and reprehensible act. For instace, as of February 2024, the Health Resources & Services Administration reported approximately 103,223 individuals including men, women, and children on the U.S. national organ transplant waiting list. This high demand for transplant procedures in major countries is expected to significantly drive market growth during the forecast period.

Key Market Drivers

Growing Organ Failures and Organ Donations Procedure

The demand for organ transplantation has been on the rise globally in the past decade. This can be attributed to the increased prevalence of vital organ failure, higher success rates of transplantation, and improved post-transplant outcomes. The incidence of organ failure has also increased due to factors such as alcohol consumption, substance abuse, and unhealthy diets leading to chronic diseases affecting vital organs like lungs, kidneys, and liver. Organ transplantations have become a life-saving measure for patients, which is driving the growth of the transplantation market. The technological advancements in transplantation methods are contributing to the overall market revenue growth. The increasing prevalence of chronic diseases leading to organ failures is a significant driver for market growth. The global rise in organ donation has also influenced people to opt for organ transplantation, thereby accelerating market expansion. The the excessive consumption of alcohol and unhealthy dietary habits among the population contribute to organ failure, further augmenting market growth. The proliferation of personal insurance, coupled with lifestyle factors contributing to the burden of illness, is projected to bolster market growth. The procurement and preservation of organs and tissues are expected to provide further impetus to market expansion. In March 2023, the Pan American Health Organization (PAHO) and Spain's Ministry of Health signed an agreement aimed at strengthening the organ donation and transplantation sector in the United States. This collaboration seeks to enhance healthcare systems, share best practices, and promote policies that increase organ availability, ultimately addressing the growing demand for transplants across the country. This strategic partnership highlights the importance of international cooperation in overcoming organ shortages and improving transplant outcomes.

Key Market Challenges

Transplant Rejection

Transplant rejection is a complex process whereby the recipient's immune system mounts an attack against the transplanted organ or tissue, recognizing it as foreign. Three types of rejections are commonly observed: hyper-acute rejection, acute rejection, and chronic rejection. Despite meticulous donor matching, tissue typing, and the use of immunosuppressive medications, instances of transplant rejection still occur, leading to organ failure. Non-compliance with immunosuppressive drugs remains a significant contributing factor to rejection. Complications that may arise from transplant rejection include certain types of cancers, infections, impaired function of the transplanted tissue or organ, and adverse effects due to incorrect medication dosages. According to the Organ Procurement and Transplantation Network, approximately 4% of deceased donor kidney transplants experience failure within one year, while living donor kidney transplant recipients face a 14% failure rate at five years post-transplant. Consequently, these factors pose challenges to the growth of the market.

Key Market Trends

Advances In the Technology and Development

Advances in technology and development have the potential to significantly boost the demand for organ transplants in the future by addressing some of the challenges and limitations currently faced by the field. Progress in technology and advancements in the medical field have facilitated the transplantation of vital organs like the heart, kidney, liver, lungs, and various other organs. Key technical achievements encompass the development of vascular anastomosis techniques, effective management of the immune response through chemical immunosuppressants, and the formulation of preservation solutions. For instance, in June 2023, 3D BioFibR introduced μCollaFibR, a bio-ink additive, and CollaFibR 3D scaffold, an advanced collagen fiber product designed for bioprinting tissue and organ models. These innovations aim to enhance the precision and functionality of bioprinted structures, supporting the development of next-generation solutions in regenerative medicine and transplantation.

These advancements can improve organ availability, enhance transplant success rates, and expand the possibilities for transplantation. Technology has the potential to improve organ preservation and transportation methods, enabling organs to remain viable for longer periods before transplantation. This can lead to more efficient organ allocation, reduced wastage, and broader access to viable organs. Advances in bioprinting and tissue engineering are enabling the creation of bioengineered organs and tissues in the laboratory. This technology has the potential to address organ shortages by producing organs on demand, reducing the dependency on donor organs. Developments in immunosuppressive medications can lead to more targeted and effective treatments that minimize the risk of organ rejection. Improved immunosuppressive protocols can increase the success rate of transplant surgeries and reduce the need for high doses of medication. Research into xenotransplantation, the transplantation of organs from animals to humans, holds the potential to overcome the shortage of human donor organs. Advances in genetic editing and immunomodulation are making xenotransplantation more feasible and safer.

Key Market Players

• Abbvie, Inc.
• Arthrex, Inc.
• Zimmer Biomet
• Medtronic plc
• Novartis AG
• Stryker Corporation
• 21st Century Medicine
• BiolifeSolutions, Inc.
• Teva Pharmaceuticals Industries Ltd.
• Veloxis Pharmaceutical Inc.

Report Scope:

In this report, the Global Organ Transplant Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Organ Transplant Market, By Product:

• Tissue Products
• Organ Preservation Products
• Transplant Diagnostics
• Immunosuppressant Drugs
• Others

Organ Transplant Market, By Application:

• Organ Transplantation
• Tissue Transplantation

Organ Transplant Market, By Type of Transplant:

• Autograft
• Allograft
• Others

Organ Transplant Market, By End User:

• Hospitals
• Transplant Centers
• Others

Organ Transplant Market, By Region:

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Organ Transplant Market.

Available Customizations:

Global Organ Transplant market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validations
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Organ Transplant Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Product (Tissue Products, Organ Preservation Products, Transplant Diagnostics, Immunosuppressant Drugs, Others)
  • 5.2.2. By Application (Organ Transplantation, Tissue Transplantation)
  • 5.2.3. By Type of Transplant (Autograft, Allograft, Others)
  • 5.2.4. By End User (Hospitals, Transplant Centers, Others)
  • 5.2.5. By Region
  • 5.2.6. By Company (2024)
• 5.3. Market Map

6. North America Organ Transplant Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Product
  • 6.2.2. By Application
  • 6.2.3. By Type of Transplant
  • 6.2.4. By End User
  • 6.2.5. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Organ Transplant Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Product
      • 6.3.1.2.2. By Application
      • 6.3.1.2.3. By Type of Transplant
      • 6.3.1.2.4. By End User
  • 6.3.2. Canada Organ Transplant Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Product
      • 6.3.2.2.2. By Application
      • 6.3.2.2.3. By Type of Transplant
      • 6.3.2.2.4. By End User
  • 6.3.3. Mexico Organ Transplant Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Product
      • 6.3.3.2.2. By Application
      • 6.3.3.2.3. By Type of Transplant
      • 6.3.3.2.4. By End User

7. Europe Organ Transplant Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Product
  • 7.2.2. By Application
  • 7.2.3. By Type of Transplant
  • 7.2.4. By End User
  • 7.2.5. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Organ Transplant Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Product
      • 7.3.1.2.2. By Application
      • 7.3.1.2.3. By Type of Transplant
      • 7.3.1.2.4. By End User
  • 7.3.2. United Kingdom Organ Transplant Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Product
      • 7.3.2.2.2. By Application
      • 7.3.2.2.3. By Type of Transplant
      • 7.3.2.2.4. By End User
  • 7.3.3. Italy Organ Transplant Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Product
      • 7.3.3.2.2. By Application
      • 7.3.3.2.3. By Type of Transplant
      • 7.3.3.2.4. By End User
  • 7.3.4. France Organ Transplant Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Product
      • 7.3.4.2.2. By Application
      • 7.3.4.2.3. By Type of Transplant
      • 7.3.4.2.4. By End User
  • 7.3.5. Spain Organ Transplant Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Product
      • 7.3.5.2.2. By Application
      • 7.3.5.2.3. By Type of Transplant
      • 7.3.5.2.4. By End User

8. Asia-Pacific Organ Transplant Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Product
  • 8.2.2. By Application
  • 8.2.3. By Type of Transplant
  • 8.2.4. By End User
  • 8.2.5. By Country
• 8.3. Asia-Pacific: Country Analysis
  • 8.3.1. China Organ Transplant Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Product
      • 8.3.1.2.2. By Application
      • 8.3.1.2.3. By Type of Transplant
      • 8.3.1.2.4. By End User
  • 8.3.2. India Organ Transplant Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Product
      • 8.3.2.2.2. By Application
      • 8.3.2.2.3. By Type of Transplant
      • 8.3.2.2.4. By End User
  • 8.3.3. Japan Organ Transplant Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Product
      • 8.3.3.2.2. By Application
      • 8.3.3.2.3. By Type of Transplant
      • 8.3.3.2.4. By End User
  • 8.3.4. South Korea Organ Transplant Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Product
      • 8.3.4.2.2. By Application
      • 8.3.4.2.3. By Type of Transplant
      • 8.3.4.2.4. By End User
  • 8.3.5. Australia Organ Transplant Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Product
      • 8.3.5.2.2. By Application
      • 8.3.5.2.3. By Type of Transplant
      • 8.3.5.2.4. By End User

9. South America Organ Transplant Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Product
  • 9.2.2. By Application
  • 9.2.3. By Type of Transplant
  • 9.2.4. By End User
  • 9.2.5. By Country
• 9.3. South America: Country Analysis
  • 9.3.1. Brazil Organ Transplant Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Product
      • 9.3.1.2.2. By Application
      • 9.3.1.2.3. By Type of Transplant
      • 9.3.1.2.4. By End User
  • 9.3.2. Argentina Organ Transplant Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Product
      • 9.3.2.2.2. By Application
      • 9.3.2.2.3. By Type of Transplant
      • 9.3.2.2.4. By End User
  • 9.3.3. Colombia Organ Transplant Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Product
      • 9.3.3.2.2. By Application
      • 9.3.3.2.3. By Type of Transplant
      • 9.3.3.2.4. By End User

10. Middle East and Africa Organ Transplant Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Product
  • 10.2.2. By Application
  • 10.2.3. By Type of Transplant
  • 10.2.4. By End User
  • 10.2.5. By Country
• 10.3. MEA: Country Analysis
  • 10.3.1. South Africa Organ Transplant Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Product
      • 10.3.1.2.2. By Application
      • 10.3.1.2.3. By Type of Transplant
      • 10.3.1.2.4. By End User
  • 10.3.2. Saudi Arabia Organ Transplant Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Product
      • 10.3.2.2.2. By Application
      • 10.3.2.2.3. By Type of Transplant
      • 10.3.2.2.4. By End User
  • 10.3.3. UAE Organ Transplant Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Product
      • 10.3.3.2.2. By Application
      • 10.3.3.2.3. By Type of Transplant
      • 10.3.3.2.4. By End User

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Porter's Five Forces Analysis

• 13.1. Competition in the Industry
• 13.2. Potential of New Entrants
• 13.3. Power of Suppliers
• 13.4. Power of Customers
• 13.5. Threat of Substitute Products

14. Competitive Landscape

• 14.1. Abbvie, Inc.
  • 14.1.1. Business Overview
  • 14.1.2. Company Snapshot
  • 14.1.3. Products & Services
  • 14.1.4. Financials (As Reported)
  • 14.1.5. Recent Developments
  • 14.1.6. Key Personnel Details
  • 14.1.7. SWOT Analysis
• 14.2. Arthrex, Inc.
• 14.3. Zimmer Biomet
• 14.4. Medtronic plc
• 14.5. Novartis AG
• 14.6. Stryker Corporation
• 14.7. 21st Century Medicine
• 14.8. BiolifeSolutions, Inc.
• 14.9. Teva Pharmaceuticals Industries Ltd.
• 14.10. Veloxis Pharmaceutical Inc.

15. Strategic Recommendations

16. About Us & Disclaimer